Alx Oncology Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.07

-0.13 (-5.91%)

As of Jun 30, 10:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +1,143.0% upside

Low Target $15.89

Average Target $25.73

High Target $34.39

Current Price $2.07

Current
$2.07

Target
$25.73

$15.89 $25.73 avg $34.39

Scenario Analysis

Bear Case

$15.89

667.6%

Low target

Base Case

$25.73

+1,143.0%

Avg target

Bull Case

$34.39

+1,561.4%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.66

-22.2% from high

52-Week Low

$0.40

+412.4% from low

Target vs 52W High

$25.73

+867.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%